TCTAP C-022 STEMI with Heavy Thrombus Burden
نویسندگان
چکیده
منابع مشابه
Thrombus aspiration in STEMI revisited: impact on coronary microcirculation?
Correspondence to Dr Georg M Fröhlich; [email protected] In this issue of Open Heart, Hoole et al present the IMPACT trial. The authors investigate the effect of thrombus aspiration (TA) on changes in microvascular function during primary percutaneous coronary intervention (PPCI) for ST elevation myocardial infarction (STEMI). However, no difference between the TA group and the control gro...
متن کاملThrombus aspiration might reduce the need for concomitant stenting in young patients with STEMI.
We have greatly enjoyed reading the article by Jamil and coworkers entitled “Lone aspiration thrombectomy” without stenting in young patients with ST elevation myocardial infarction [1]. In that successfully planned study, the authors aimed to research the safety of a strategy of lone thrombus aspiration (TA), without added balloon dilation or stenting, in selected ST elevation myocardial infar...
متن کاملDual antiplatelet agents and Rivaroxaban for massive intracoronary thrombus in STEMI
Management of intracoronary thrombus in patients presenting more than 12 hours after the onset of ST elevation myocardial infarction is challenging. We present such a case which had massive thrombus in left anterior descending artery. It was managed successfully with dual antiplatelet agents and factor Xa inhibitor rivaroxaban administered orally.
متن کاملThrombus burden quantification: an evolving tool for coronary interventions
Thrombus is a distinctive histo-pathological feature of patients presenting with STelevation myocardial infarction (STEMI) and constitutes an adverse finding that significantly affects interventional management. Characterization and quantification of coronary thrombi have been a challenge since the beginning of thrombolysis era. Almost 20 years ago, the Thrombolysis in Myocardial Infarction (TI...
متن کاملHigh coronary plaque load: a heavy burden.
Hydroxymethylglutaryl (HMG) CoA-reductase inhibitors, or statins, play an important role in the primary and secondary prevention of coronary heart disease. By inhibiting the enzyme HMG-CoA reductase, statins lower the production of cholesterol in the liver, resulting in lower LDL cholesterol levels. Besides lowering cholesterol levels, statin therapy slows down plaque progression and in some pa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2021
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2021.03.125